John Y Kao, MD
Associate Chair, Department of Internal Medicine
Professor of Internal Medicine, Medical School
Email:
[email protected]
Phone:
Available to mentor
John Y Kao, MD
Professor
Manage Your Profile
Center Memberships
-
Center MemberMM-PKUHSC Joint Institute
-
Center MemberRogel Cancer Center
-
Center MemberGlobal REACH
Recent Publications
-
Hsu P-I, Chan FKL, Sugano K, Kim B-W, Kao JY, Wu D-C. Gastroenterology, 2026 Sep 23;Journal ArticleFinishing the Unfinished Agenda: Monoantibiotic Strategies for Helicobacter pylori in the Era of Rising Resistances.
DOI:10.1053/j.gastro.2026.04.048 PMID: 42777970 -
Newman KL, Lee AA, Singh P, Kao JY, Chey WD, Higgins PDR. Clin Gastroenterol Hepatol, 2026 Sep 7;Journal ArticleIncreases in Probiotic Supplement Use Exceed Microbiome-Focused Dietary Changes in United States Adults and Children.
DOI:10.1016/j.cgh.2026.08.029 PMID: 42705429 -
Hsu PI, Sheu MJ, Chen CL, Lei WY, Shih CA, Tsay FW, Kao SS, Shie CB, Wu PJ, Kuo CH, Yang JC, Chen KY, Chuah SK, Lee CL, Lee HC, Tai WC, Tsai TJ, Kao JY, Wu DC. Helicobacter, 2026 Jul 1; 31 (4):Journal ArticleBismuth–Amoxicillin–Vonoprazan Triple, Amoxicillin–Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial
DOI:10.1111/hel.70131 PMID: 42639978 -
Kao SS, Wu DC, Chuah SK, Kao JY, Tai WC, Shie CB, Wu IT, Chen WC, Tsay FW, Chen YH, Hsu PI. Journal of the Formosan Medical Association, 2026 Jun 1; 125 (6): 636 - 642.Journal ArticleComparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus
DOI:10.1016/j.jfma.2025.03.006 PMID: 40069015 -
Tung C-C, Lee H-C, Kuo I-N, Cheng M-L, Wang H-L, Chen J-D, Tu W-K, Kao JY, Yang J-C. Gastrointestinal Endoscopy, 2026 May 3; 103 (5): s - 2522.Journal Article866 COMPARATIVE EFFICACIES OF MORE SENSITIVE SUSCEPTIBILITY-GUIDED VS EMPIRIC OPTIMIZED BISMUTH QUADRUPLE SALVAGE THERAPIES FOR PERSISTENT H. PYLORI INFECTION - AN INTERIM REPORT OF A MULTI-CENTER, RANDOMIZED CONTROLLED STUDY
DOI:10.1016/s0016-5107(26)05913-4 -
Tung C-C, Lee H-C, Kuo I-N, Cheng M-L, Wang H-L, Chen J-D, Tu W-K, Kao JY, Yang J-C. Gastroenterology, 2026 May 2; 170 (6): s - 2522.Journal Article866 COMPARATIVE EFFICACIES OF MORE SENSITIVE SUSCEPTIBILITY-GUIDED VS EMPIRIC OPTIMIZED BISMUTH QUADRUPLE SALVAGE THERAPIES FOR PERSISTENT H. PYLORI INFECTION - AN INTERIM REPORT OF A MULTI-CENTER, RANDOMIZED CONTROLLED STUDY
DOI:10.1016/s0016-5085(26)05982-2 -
Liu Y-H, Wu I-T, Tsai T-J, Hsu P-I, Wu D-C, Kao J. Gut, 2026 Mar 6;Journal ArticleOptimising mono-antibiotic eradication regimen by potent acid inhibitor and bismuth: a potential solution to rising clarithromycin resistance in Helicobacter pylori.
DOI:10.1136/gutjnl-2026-338544 PMID: 41791850 -
Sanders GM, Hua A, Hudson E, Troost JP, Kamada N, Kao JY, Schuler CF, El-Zaatari M. Allergy Asthma and Clinical Immunology, 2026 May 28; 21 (1):Journal ArticleAssociation of myeloid cell reactivity patterns with safe food predictions in FPIES patients
DOI:10.1186/s13223-025-00968-1
